Mvasi

Active Ingredient(s): Bevacizumab-awwb
FDA Approved: * September 14, 2017
Pharm Company: * AMGEN INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mvasi Overview

Bevacizumab, sold under the brand name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.[9][10] For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy.[9][10] For age-related macular degeneration it is given by injection into the eye...

Read more Mvasi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bevacizumab

Recent Mvasi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bevacizumab-awwb
  • Injection: 100mg/4ml, 100mg/4ml (25mg/ml), 25mg/ml, 400mg/16ml, 400mg/16ml (25mg/ml)
  • Vial: 100mg, 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mvasi: (2 results)

Sorted by National Drug Code
  • 55513-206 Mvasi 100 mg/4ml Intravenous Injection, Solution by Amgen Inc
  • 55513-207 Mvasi 400 mg/16ml Intravenous Injection, Solution by Amgen Inc

Other drugs which contain Bevacizumab-awwb or a similar ingredient: (4 results)